| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Chief Accounting Officer | SVP, Finance &CAO | SVP, Finance &CAO +1 more
1 company
Utter Christine Marie is a SVP, Chief Accounting Officer at PTCT. Recent filings cover 0 purchases and 80 sales. Those positions are worth an estimated $5.3M at current prices.
Our model assigns Utter Christine Marie a middling insider score of 58/100, based on 22 past trades. Over a 12-month horizon, 36.8% of those trades were profitable, with an average 12-month return of -11.8%.
Utter Christine Marie's largest disclosed position is in PTCT as SVP, Chief Accounting Officer, worth about $5.3M. The recent filings there lean toward selling, a net 212,611 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17, 2026 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sale+OE10b5-1 | 19,686 | $75.56 | $1,487,474.16 | -21.9% | -16.4% | - | |
| Feb 18, 2026 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell10b5-1 | 2,494 | $69.36 | $172,983.84 | -3.4% | +2.0% | - | |
| Jan 8, 2026 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell10b5-1 | 1,034 | $76.45 | $79,049.30 | -1.4% | -7.3% | - | |
| Jan 7, 2026 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell10b5-1 | 2,616 | $77.19 | $201,918.70 | -3.4% | -9.9% | - | |
| Feb 20, 2025 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell10b5-1 | 1,757 | $50.11 | $88,043.26 | -2.7% | -8.3% | +40.3% | |
| Jan 8, 2025 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell10b5-1 | 2,953 | $44.87 | $132,492.94 | -4.4% | -11.7% | +70.6% | |
| Dec 2, 2024 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sale+OE10b5-1 | 17,800 | $51.77 | $921,585.17 | -25.3% | +1.5% | +50.7% | |
| Jan 30, 2024 | PTCT Ptc Therapeutics, Inc. | SVP, Chief Accounting Officer | Sell10b5-1 | 318 | $27.25 | $8,665.75 | -0.9% | +21.0% | +70.3% | |
| Jan 9, 2024 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sell10b5-1 | 2,841 | $28.86 | $81,986.14 | -7.3% | -6.4% | +56.9% | |
| Apr 21, 2023 | PTCT Ptc Therapeutics, Inc. | SVP, Finance &CAO | Sale+OE10b5-1 | 4,692 | $55.06 | $258,325.90 | -11.0% | -29.0% | -54.1% |